ArticleBMC pediatrics2026
Expert collaboration for safe perinatal stabilization of neonates with select critical congenital heart defects at non-cardiac centers.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate mortality and morbidity among neonates with select critical congenital heart defects (cCHD) delivered and initially managed at a Level-III perinatal center without in-house paediatric cardiac surgery, and to determine how many required immediate cardiac interventions versus stabilization prior to transfer.
designRetrospective single-center cohort study (2018–2022) at a Level-III perinatal center with neonatologists and paediatric cardiologists on-site but no paediatric cardiac intervention unit. Inclusion of all neonates with prenatally or postnatally suspected cCHD delivered at the center and managed until transfer or discharge.
interventionsStructured neonatal care including prostaglandin therapy, respiratory support, and coordination with a tertiary cardiac center. Immediate non-surgical cardiac interventions were performed in-house when necessary.
main outcome measuresPre- and postnatal diagnosis, neonatal mortality, morbidity, need for immediate cardiac intervention, postnatal bonding, and timing of transfer.
resultsA total of 115 neonates were included; 94.0% had a prenatal cCHD diagnosis. Immediate non-surgical cardiac intervention was required in 3 neonates (2.6%) including emergency atrial septostomy performed on-site. The remaining 112 neonates (97.4%) were stabilized without the need for immediate intervention before transfer. Prostaglandin E1 infusion was initiated in 67.0% of neonates to maintain ductal patency. Median time to transfer was 4 days (IQR 3–7). Postnatal bonding occurred in 52.7% of cases despite the complexity of care. No neonates experienced acute in-house mortality during stabilization. Overall mortality was 9.6%, with 81.8% of deaths occurring after transfer and 18.2% following in-house palliative care based on prenatal counselling decisions.
conclusionsMost neonates with cCHD can be safely stabilized at a Level-III perinatal center prior to transfer without the need for immediate surgical cardiac intervention. The model allows for effective care and maternal bonding without increased acute mortality. These findings support collaborative perinatal management outside surgical cardiac centers for selected cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.